Palmer D B, Crompton T, Marandi M B, George A J, Ritter M A
Department of Immunology, Division of Medicine, MRC, Clinical Science Center, Imperial College School of Medicine, Hammersmith Hospital, London, UK.
Immunology. 1999 Feb;96(2):236-45. doi: 10.1046/j.1365-2567.1999.00691.x.
The mouse monoclonal antibody MR6 recognizes a 200 000 MW protein (gp200-MR6), which is expressed highly on human thymic cortical epithelial cells. The antigen is also expressed on some epithelial tumours and we have previously shown that MR6 inhibits the proliferation of the colon carcinoma cell lines HT29. However, the role of this molecule in the thymus is not known. In order to generate reagents that could be used in murine thymic functional studies we isolated antibodies specific to human gp200-MR6, using a phage display library expressing single-chain (sFv) antibodies. Three independent clones were isolated by panning with purified protein and their specificity was confirmed by immunohistochemistry, Western blotting and flow cytometry. In addition to human thymus, these phage antibodies also recognized the homologous antigen in mouse, pig and other species. Expressed as soluble sFv one of these clones inhibited the proliferation of HT29 cells and a mouse thymic epithelial cell line, suggesting that this antibody exhibits similar functional activity to MR6. In fetal thymic organ culture, thymocytes recovered from thymic lobes cultured in the presence of this sFv, were reduced in number fivefold compared with the control and the majority remained at the double-negative stage of development. These data indicate that gp200-MR6 plays an important role in thymocyte development. In addition, this is the first report to demonstrate that specific sFv can be used to study, and alter, thymic development. This work also highlights the advantage of phage antibody technology in selecting such reagents for functional assays.
小鼠单克隆抗体MR6可识别一种分子量为200 000的蛋白质(gp200-MR6),该蛋白质在人胸腺皮质上皮细胞上高度表达。该抗原在一些上皮肿瘤中也有表达,我们之前已表明MR6可抑制结肠癌细胞系HT29的增殖。然而,该分子在胸腺中的作用尚不清楚。为了制备可用于小鼠胸腺功能研究的试剂,我们利用表达单链(sFv)抗体的噬菌体展示文库,分离出了针对人gp200-MR6的特异性抗体。通过用纯化蛋白淘选分离出了三个独立克隆,并通过免疫组织化学、蛋白质印迹法和流式细胞术证实了它们的特异性。除人胸腺外,这些噬菌体抗体还识别小鼠、猪和其他物种中的同源抗原。其中一个克隆表达为可溶性sFv后,可抑制HT29细胞和小鼠胸腺上皮细胞系的增殖,这表明该抗体具有与MR6相似的功能活性。在胎儿胸腺器官培养中,与对照组相比,在该sFv存在下培养的胸腺叶中回收的胸腺细胞数量减少了五倍,且大多数细胞仍处于双阴性发育阶段。这些数据表明gp200-MR6在胸腺细胞发育中起重要作用。此外,这是首次证明特异性sFv可用于研究和改变胸腺发育的报告。这项工作还突出了噬菌体抗体技术在选择此类试剂进行功能测定方面的优势。